Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E52.24 EPS (ttm)2.27 Insider Own11.20% Shs Outstand1.08B Perf Week1.45%
Market Cap128.61B Forward P/E20.29 EPS next Y5.86 Insider Trans-3.13% Shs Float1.06B Perf Month8.69%
Income2.36B PEG3.86 EPS next Q1.35 Inst Own79.50% Short Float0.88% Perf Quarter6.14%
Sales24.28B P/S5.30 EPS this Y-37.00% Inst Trans-0.69% Short Ratio1.89 Perf Half Y33.65%
Book/sh12.82 P/B9.27 EPS next Y4.93% ROA1.00% Target Price117.47 Perf Year39.03%
Cash/sh8.35 P/C14.23 EPS next 5Y13.55% ROE3.50% 52W Range73.69 - 119.84 Perf YTD2.65%
Dividend2.25 P/FCF56.61 EPS past 5Y-15.00% ROI6.60% 52W High-0.88% Beta0.36
Dividend %1.89% Quick Ratio1.50 Sales past 5Y0.20% Gross Margin73.40% 52W Low61.20% ATR2.76
Employees40655 Current Ratio1.90 Sales Q/Q7.10% Oper. Margin12.30% RSI (14)58.80 Volatility1.64% 2.33%
OptionableYes Debt/Eq0.97 EPS Q/Q112.90% Profit Margin1.90% Rel Volume0.81 Prev Close117.09
ShortableYes LT Debt/Eq0.89 EarningsFeb 13 BMO Payout492.40% Avg Volume4.91M Price118.79
Recom2.40 SMA203.60% SMA504.43% SMA20019.35% Volume3,972,137 Change1.45%
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Jan-23-19 10:48AM  5 Best Biotech Bets Likely to Outperform Estimates in Q4 Zacks
10:27AM  How Many Insiders Bought Eli Lilly and Company (NYSE:LLY) Shares? Simply Wall St.
08:37AM  6 Stocks to Prepare for a Global Economic Slowdown Zacks
08:00AM  Government Employees Affected by Federal Shutdown Encouraged to Contact Lilly Diabetes Solution Center to Access Insulin PR Newswire
Jan-22-19 06:19PM  U.S. insulin costs per patient nearly doubled from 2012 to 2016 -study Reuters
09:57AM  J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft Zacks
09:30AM  Company News For Jan 22, 2019 Zacks
06:00AM  U.S. insulin costs per patient nearly doubled from 2012 to 2016 -study Reuters
Jan-21-19 04:15PM  Lilly Confirms Date and Conference Call for Fourth-Quarter 2018 Financial Results Announcement PR Newswire
01:33PM  Lilly Stops Lartruvo Promotion as Confirmatory Study Fails Zacks
Jan-18-19 07:42PM  [$$] Eli Lillys Sarcoma Drug Combo Proves Ineffective in Trials The Wall Street Journal
07:02PM  Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirumab) in Second-Line AFP-High Hepatocellular Carcinoma Patients PR Newswire
04:28PM  Eli Lilly Slides as Sarcoma Treatment Fails in Phase 3 Trial TheStreet.com
04:08PM  Highly Rated Pharma Dips On Drug Failure Is Its Buy Point At Risk? Investor's Business Daily
03:08PM  Eli Lilly News: LLY Stock Falls on Sarcoma Study Failure InvestorPlace
02:01PM  Lilly cancer drug fails key trial, will no longer be prescribed Reuters
01:40PM  Lilly cancer drug fails key trial, will no longer be prescribed Reuters
01:02PM  [$$] Lilly's Sarcoma Drug Combo Proves Ineffective in Trials The Wall Street Journal
12:43PM  Health care, retail, biotech & emerging markets in the bl... CNBC Videos
12:01PM  Stocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & more CNBC
09:36AM  Dow jumps 160 points as stock market set to end week with solid gains on China-trade optimism MarketWatch
09:11AM  Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY Zacks
09:01AM  Here is Why Growth Investors Should Buy Lilly (LLY) Now Zacks
07:59AM  Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & more CNBC
07:02AM  Lilly's cancer therapy Lartruvo fails to meet main goal in late-stage trial Reuters
06:59AM  Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment MarketWatch
06:45AM  Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO® PR Newswire
Jan-17-19 07:06PM  Pacira's Study on Exparel Label Expansion Meets Endpoints Zacks
03:50PM  Lilly's 10-Day Sprint For Loxo Could Put Other Names On The Table Investor's Business Daily
11:31AM  Ligand (LGND) Takes a Hit on Citron's Negative Research Report Zacks
06:55AM  Citron Says Ligand Has 80% Downside in Explosive Note Investopedia
Jan-16-19 07:15PM  Dealmaking surge confirms the stock market got far too ch... CNBC Videos
07:01PM  Jim Cramer: There's a Ton More Deals in the Pipe TheStreet.com
05:06PM  5 Health Care Stocks in Gurus' Portfolios GuruFocus.com
04:26PM  Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings Zacks
04:19PM  Intrexon Signs Licensing Agreement with Next Green Wave Zacks
04:18PM  Ligand Crashes To Nearly 2-Year Low After Short-Seller Bashes It Investor's Business Daily
12:53PM  Goldman's Gold Standard in M&A Bolsters Outlook for 2019 TheStreet.com
12:51PM  Takeda Wraps Its Shire Buyout, CEO Sees More Mergers Coming Investor's Business Daily
09:25AM  6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019 Zacks
Jan-15-19 04:19PM  Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter Investor's Business Daily
04:16PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of Loxo Oncology, Inc. to Eli Lilly and Company is Fair to Shareholders GlobeNewswire
09:40AM  Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer Zacks
Jan-14-19 06:09PM  Eli Lilly CEO Predicts 2019 Will Be Big Year for Biotech Acquisitions GuruFocus.com
06:00PM  Democrats target drug prices CNBC Videos
05:50PM  Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know Zacks
04:22PM  Will Biogen Jump On This Biotech Stock Amid Buying Spree? Investor's Business Daily
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
Jan-13-19 06:01PM  Here's Why Eli Lilly Stock Surged 37% in 2018 Motley Fool
03:50PM  The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
06:30AM  Here's Why Loxo Oncology Soared 66.4% in 2018, and Another 66% Since Motley Fool
Jan-11-19 05:36PM  5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019 Zacks
04:08PM  Stock Market Rally Runs Into Resistance; Boeing, GM, Macy's, American Airlines: Weekly Review Investor's Business Daily
04:06PM  Lilly eyes more cancer deals, but wary of CAR-T, gene therapy Reuters
03:06PM  7 Pharmaceutical Stocks That Just Raised Prices This Year InvestorPlace
10:38AM  Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why Zacks
10:31AM  Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference CNBC
09:59AM  The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock InvestorPlace
09:45AM  Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet Zacks
07:46AM  The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference Motley Fool
06:22AM  4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019 Zacks
Jan-10-19 04:13PM  Will Pfizer Join The Buying Spree With This Small Biotech Stock? Investor's Business Daily
03:23PM  3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year Motley Fool
02:49PM  3 Defensive ETFs to Protect Yourself From Another Market Selloff InvestorPlace
09:56AM  Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting Zacks
Jan-09-19 07:32PM  [$$] Big Pharmas Cancer Race The Wall Street Journal
02:32PM  CNBC'S CHRISTINA FARR & ANGELICA LAVITO: JP MORGAN'S DIMON HOSTED A DINNER FOR PHARMA EXECUTIVES, AND A MAJOR TOPIC WAS AMAZON CNBC
01:29PM  JP Morgan's Dimon hosted a dinner for pharma executives, and a major topic was Amazon CNBC
11:56AM  MERGER ALERT BDMS, LOXO and MB: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies GlobeNewswire
08:51AM  The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo Zacks
08:31AM  Novartis' Crizanlizumab Gets Breakthrough Therapy Status Zacks
08:25AM  Does Eli Lilly's $8 Billion Splurge Make Array BioPharma a Buy Now? Motley Fool
07:25AM  Report: Exploring Fundamental Drivers Behind Virtusa, Eli Lilly, Cree, NewJersey Resources, Getty Realty, and PennantPark Investment New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
07:00AM  A Pension Fund Bought Apple Stock at the Wrong Time Barrons.com
Jan-08-19 07:16PM  Would-Be Dealmakers Warn of M&A, IPO Delays Due to Shutdown Bloomberg
05:27PM  Eli Lilly giving price info on advertised drugs via website Associated Press
05:01PM  Why Eli Lilly Is Buying Loxo Oncology for $8 Billion Motley Fool
03:12PM  WEISSLAW LLP: Loxo Oncology, Inc. Acquisition May Not Be In The Best Interests of LOXO Shareholders PR Newswire
11:02AM  Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy Reuters
10:53AM  Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy Reuters
10:00AM  Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy? Zacks
09:58AM  Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo Zacks
09:52AM  Crowded Cancer Space Triggers Big M&A Deals: More in Store? Zacks
09:30AM  Company News For Jan 8, 2019 Zacks
08:56AM  4 Biotechs That Are Potential Buyouts Post Celgene Deal Zacks
08:46AM  Is Eli Lilly Overpaying for Loxo Oncology? Motley Fool
08:00AM  Two ways to play the biotech boom CNBC
07:00AM  Debt Buybacks Could Be The New Stock Buybacks Barrons.com
12:36AM  Deal-making in the global health-care sector is set to rebound in 2019, law firm says CNBC
Jan-07-19 11:38PM  Asian shares mixed amid silence on China-US trade talks Associated Press
10:48PM  [$$] Eli Lilly to Buy Loxo Oncology in $8 Billion Deal The Wall Street Journal
10:14PM  Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy Reuters
08:44PM  Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way Bloomberg
08:14PM  PRESS DIGEST- Financial Times - Jan 8 Reuters
08:14PM  [$$] Good News for Biotech: Shoppers Unfazed by Selloff The Wall Street Journal
07:38PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Loxo Oncology, Inc. (LOXO) on Behalf of Stockholders and Encourages LOXO Investors to Contact the Firm GlobeNewswire
07:01PM  Jim Cramer: These Pharma Deals Are Game Changers TheStreet.com
06:49PM  Biotech Stocks Post Double-Digit Gains in Monday Surge TheStreet.com
05:58PM  Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy Reuters
05:50PM  Eli Lilly (LLY) Gains But Lags Market: What You Should Know Zacks
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; and Dicerna Pharmaceuticals, Inc., as well as has strategic collaboration with Sigilon Therapeutics and AC Immune SA. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048048Feb 21 10:28 AM
Zakrowski Donald AChief Accounting OfficerFeb 05Sale81.0990072,9814,130Feb 05 06:39 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 05Sale81.129,625780,780133,201Feb 05 06:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.009,596080,234Sep 24 04:45 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 01Option Exercise0.0021,3260152,120Feb 05 06:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0015,993065,357Feb 05 06:33 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0021,3260140,809Feb 05 06:31 PM
Mahony SusanSVP & Pres., Lilly OncologyFeb 01Option Exercise0.0021,326060,350Feb 05 06:24 PM
Lundberg Jan MEVP,Science&Tech and Pres. LRLFeb 01Option Exercise0.0036,2520214,295Feb 05 06:21 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0024,5240102,738Feb 05 06:19 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0017,0600107,820Feb 05 06:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0021,3260147,980Feb 05 06:12 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.006,398022,107Feb 05 06:09 PM